Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.

TSXV:HEM - Post by User

Hemostemix Inc > Nasdaq requirements readily achievable

<< Previous

Bullboard Posts

Next >>

Comment by auricgoldon Dec 28, 2020 7:08pm

175 Views

Post# 32188919

RE:Nasdaq requirements readily achievable

a good sponsoring in NY is doable. We walk before we run and I am sure we will run to the 5$ mark and funding in 2021 and a NASDAQ application in process.

Pimpovish wrote:
The below considerations for a Nasdaq listing are far from onerous. Assuming, the full raise of $2.75 million at 1.5 cents, the total share count will be just under 56 million shares post 20:1 rollback. At $3 a share, the market capitalization would only be $168 million Cdn. With good midpoint numbers, we should get closer to this level. The things to keep in mind are we are currently listed on a junior Canadian exchange and are coming out of a litigious storm that was IP related. A good sponsoring broker out of New York will do wonders for magnifying and amplifying this evolving stem cell story.

What are the rules to be listed on NASDAQ?

Shareholders Equity of at least $2,000,000.

At least 100,000 shares of public float.

A minimum of 300+ shareholders.

Total assets of $4,000,000.

At least two market makers.

$3 minimum bid price of the company stock.

Public float market value of $1,000,000.

investmentbank.com › nasdaq-listin...

NASDAQ Listing Requirements - InvestmentBank.com